Loading organizations...
Loading organizations...
Figure 1 is a technology company.
Figure 1 has raised $21.0M across 4 funding rounds.
Figure 1 has raised $21.0M in total across 4 funding rounds.
Figure 1 is a peer-to-peer platform that unites healthcare professionals from over 190 countries to teach, share, and collaborate on real patient cases, improving medical knowledge and patient outcomes.
# Figure 1: Medical Collaboration Platform
Figure 1 is a healthcare technology platform that enables verified medical professionals to collaborate on real patient cases in real time.[5] The platform serves as a knowledge-sharing network where clinicians—including doctors, nurses, and specialists—can seek diagnostic advice, discuss complex cases, and learn from peers globally. The core problem it solves is clinical isolation: healthcare professionals, particularly those in resource-limited settings, often lack immediate access to specialist expertise. Figure 1 bridges this gap by creating a vetted, HIPAA-compliant community where 40% of clinicians unable to resolve cases independently find resolution through peer collaboration.[5]
The platform operates as a two-sided marketplace: on one side, it provides clinicians with a professional network for knowledge exchange; on the other, it monetizes through sponsored content and partnerships with healthcare brands and pharmaceutical companies.[4] Since its 2013 launch, Figure 1 has grown to include registered users across 190 countries, with three-quarters of U.S. medical students using the platform.[4]
Figure 1 was founded in 2013 by Gregory Levey as a photo- and knowledge-sharing app for medical professionals.[4] The platform emerged from a straightforward insight: doctors value peer expertise but resent traditional pharmaceutical and medical device marketing. Rather than building another spam channel, Levey and his team designed a platform centered on what clinicians actually wanted—authentic knowledge exchange with other verified healthcare professionals.[4]
Early traction came quickly. The platform attracted medical students and practicing physicians seeking diagnostic collaboration, and by 2017, it had expanded to include institutional partnerships with major healthcare brands including Shire, Novartis, and the CDC Foundation.[4] The company is based in Toronto and New York, positioning it at the intersection of North American healthcare innovation.
Figure 1 operates at the intersection of several powerful trends. First, it addresses the persistent fragmentation of medical knowledge—despite digitization, clinical expertise remains siloed within institutions and geographies. Second, it capitalizes on the professionalization of healthcare social networks, where clinicians increasingly seek peer learning over traditional continuing education. Third, it demonstrates how blockchain-agnostic platforms can solve real coordination problems in regulated industries through trust mechanisms (verification) rather than technology alone.
The platform's influence extends beyond individual case resolution. During public health emergencies—including Zika, MERS, and COVID-19—Figure 1 became a real-time knowledge distribution channel, allowing frontline clinicians to share emerging clinical patterns before formal literature review cycles could capture them.[5] This positions the company as critical infrastructure for pandemic preparedness and rare disease diagnosis.
Figure 1 has established itself as the de facto professional network for verified clinicians globally. Its sustainable monetization model—charging institutional partners rather than individual users—aligns with healthcare economics and reduces churn risk. The platform's value compounds as network effects strengthen: more clinicians attract more specialists, which attracts more institutional partnerships.
Looking forward, Figure 1's trajectory likely depends on deepening institutional integration. Healthcare systems and insurance companies increasingly need real-time clinical intelligence; Figure 1's data on case patterns, diagnostic approaches, and treatment outcomes represents a valuable asset for improving care delivery and reducing diagnostic errors. The company's ability to expand from a knowledge-sharing platform into a clinical decision-support tool—while maintaining professional trust—will define its next phase of growth.
Figure 1 has raised $21.0M in total across 4 funding rounds.
Figure 1's investors include Kensington Capital Partners, Acton Capital Partners, Angelic Ventures, Frazier Healthcare Partners, David Krane, Tony Florence, QED Investors, TCV, The Finger Group, Union Square Ventures, Version One Ventures, Dan Ciporin.
Figure 1 has raised $21.0M across 4 funding rounds. Most recently, it raised $10.0M Series B in June 2017.